FASENRA SCEI for Long-term Use
NCT03588546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 653
Last updated 2025-09-02
Summary
The purpose of the investigation is to confirm the safety and efficacy under the post-marketing actual long-term use of FASENRA Subcutaneous Injection 30 mg Syringe.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Toshimitsu Tokimoto · AstraZeneca KK
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-31
- Primary Completion
- 2024-09-10
- Completion
- 2024-09-10
Countries
- Japan
Study Locations
More Related Trials
-
Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
NCT05850494 ·Status: COMPLETED ·Phase: PHASE3
-
Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients
NCT03931954 ·Status: COMPLETED
-
TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)
NCT05729711 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)
NCT04808518 ·Status: COMPLETED
-
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation
NCT01232335 ·Status: COMPLETED
-
The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China
NCT01785901 ·Status: COMPLETED
-
Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
NCT01395849 ·Status: COMPLETED
-
Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma
NCT00843193 ·Status: COMPLETED ·Phase: PHASE2
-
Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand
NCT00800241 ·Status: COMPLETED
-
Study of GSK3511294 in Healthy Chinese Participants
NCT05140200 ·Status: COMPLETED ·Phase: PHASE1
-
Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
NCT01395862 ·Status: COMPLETED
-
Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma
NCT05018299 ·Status: RECRUITING ·Phase: PHASE2
-
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)
NCT03620747 ·Status: COMPLETED ·Phase: PHASE3
-
One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids
NCT00758589 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating IMA-638 in Asthma
NCT00339872 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma
NCT03976869 ·Status: COMPLETED ·Phase: PHASE1
-
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma
NCT00394121 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of SHR-1703 in Healthy Subjects
NCT04855591 ·Status: TERMINATED ·Phase: PHASE1
-
First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma
NCT03287310 ·Status: COMPLETED ·Phase: PHASE1
-
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
NCT00255255 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
NCT01704495 ·Status: COMPLETED ·Phase: PHASE2
-
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
NCT01691859 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study
NCT03387722 ·Status: COMPLETED
-
A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma
NCT01244984 ·Status: COMPLETED ·Phase: PHASE3
-
Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population
NCT02153411 ·Status: COMPLETED